These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3089850)

  • 21. Treatment of chronic discoid lupus erythematosus with an oral gold compound (auranofin).
    Dalziel K; Going G; Cartwright PH; Marks R; Beveridge GW; Rowell NR
    Br J Dermatol; 1986 Aug; 115(2):211-6. PubMed ID: 3091062
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparative study of auranofin, gold sodium thiomalate, and D-penicillamine in rheumatoid arthritis: a progress report.
    Barraclough D; Brook A; Brooks P; Boyden K; Thomas D; Tymms K
    J Rheumatol Suppl; 1982; 8():197-200. PubMed ID: 6813485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long term experience with oral gold in psoriatic arthritis.
    Barbieri P; Ciompi ML; Bini C; Pasero G
    Clin Rheumatol; 1986 Jun; 5(2):274-5. PubMed ID: 3089674
    [No Abstract]   [Full Text] [Related]  

  • 24. The efficacy and safety of auranofin compared to placebo in rheumatoid arthritis.
    Katz WA; Alexander S; Bland JH; Blechman W; Bluhm GB; Bonebrake RA; Falbo A; Greenwald RA; Hartman S; Hobbs T; Indenbaum S; Lergier JE; Lanier BG; Lightfoot RW; Phelps P; Sheon RP; Torretti D; Wenger ME; Wilske K
    J Rheumatol Suppl; 1982; 8():173-8. PubMed ID: 6813481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gold concentrations and toxicity during oral gold treatment with auranofin.
    Sharma RP; Smillie J; Palmer DG
    Pharmacology; 1985; 30(2):115-20. PubMed ID: 3919401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of auranofin, gold sodium thiomalate, and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial.
    Ward JR; Williams HJ; Egger MJ; Reading JC; Boyce E; Altz-Smith M; Samuelson CO; Willkens RF; Solsky MA; Hayes SP
    Arthritis Rheum; 1983 Nov; 26(11):1303-15. PubMed ID: 6416259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of eosinophilia during gold therapy for rheumatoid arthritis.
    Edelman J; Davis P; Owen ET
    J Rheumatol; 1983 Feb; 10(1):121-3. PubMed ID: 6405032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell-bound gold (CBG) in patients treated with aurothioglucose and with auranofin. A comparison of different methods of determination.
    van Riel PL; Gribnau FW; van de Putte LB
    J Rheumatol; 1983 Aug; 10(4):574-8. PubMed ID: 6413685
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurotoxicity following a very high dose of oral gold (auranofin).
    Gambari P; Ostuni P; Lazzarin P; Tavolato B; Todesco S
    Arthritis Rheum; 1984 Nov; 27(11):1316-7. PubMed ID: 6093822
    [No Abstract]   [Full Text] [Related]  

  • 30. Bronchiolitis in a rheumatoid arthritis patient receiving auranofin.
    O'Duffy JD; Luthra HS; Unni KK; Hyatt RE
    Arthritis Rheum; 1986 Apr; 29(4):556-9. PubMed ID: 3085683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiographic evaluation of erosion in rheumatoid arthritis: double blind study of auranofin vs placebo.
    Gofton JP; O'Brien WM; Hurley JN; Scheffler BJ
    J Rheumatol; 1984 Dec; 11(6):768-71. PubMed ID: 6440982
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of auranofin, gold sodium thiomalate, and placebo in the treatment of rheumatoid arthritis. Subsets of responses.
    Ward JR; Williams HJ; Boyce E; Egger MJ; Reading JC; Samuelson CO
    Am J Med; 1983 Dec; 75(6A):133-7. PubMed ID: 6419595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Drug information: auranofin (Ridaura). Oral administration of gold for polyarthritis].
    MMW Munch Med Wochenschr; 1983 Mar; 125(12):88-9. PubMed ID: 6406850
    [No Abstract]   [Full Text] [Related]  

  • 34. One-year comparative study of gold sodium thiomalate and auranofin in the treatment of rheumatoid arthritis.
    Davis P; Menard H; Thompson J; Harth M; Beaudet F
    J Rheumatol; 1985 Feb; 12(1):60-7. PubMed ID: 3920393
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early experiences with auranofin in juvenile rheumatoid arthritis.
    Brewer EJ; Giannini EH; Person DA
    Am J Med; 1983 Dec; 75(6A):152-6. PubMed ID: 6419599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment of rheumatoid arthritis with the oral gold preparation Auranofin].
    Trnavský K; Zbojanová M
    Cas Lek Cesk; 1982 Nov; 122(45):1382-4. PubMed ID: 6821244
    [No Abstract]   [Full Text] [Related]  

  • 37. Interim results of a multicenter open study with auranofin in Japan.
    Homma M; Abe T; Akizuki M; Shiokawa Y; Shichikawa K; Kageyama T; Yoshizawa H; Azuma T; Mizushima Y; Okazaki T; Sugawara S
    J Rheumatol Suppl; 1982; 8():160-8. PubMed ID: 6813479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Auranofin: experience to date.
    Blodgett RC
    Am J Med; 1983 Dec; 75(6A):86-9. PubMed ID: 6419601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Auranofin].
    Ferrari M; Piro MT
    Recenti Prog Med; 1983 Aug; 74(8):968-70. PubMed ID: 6417742
    [No Abstract]   [Full Text] [Related]  

  • 40. [Comparison of oral and parenteral gold therapy--review of the literature].
    Thumb N
    Wien Klin Wochenschr Suppl; 1984; 156():44-8. PubMed ID: 6442057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.